Stay updated on Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial page.

Latest updates to the Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial page
- Check3 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This appears to be a minor software version upgrade with no visible content changes.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedThe revision label was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision: v3.4.3 updated from v3.4.2.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page revision tag was updated to v3.4.2, replacing the previous v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check75 days agoChange DetectedAdded Revision: v3.4.1 and removed Revision: v3.4.0. This update does not change core page content, study data, or user-facing features.SummaryDifference0.0%

- Check82 days agoChange DetectedGlossary display has been added to the page. Text updates include capitalization changes for QC-related labels, an added FEAR Act data note, and a new site revision tag (v3.4.0) replacing the old version (v3.3.4).SummaryDifference0.2%

Stay in the know with updates to Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial page.